INTP5
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for INTP5, covering 2019-10-04 to 2019-10-04. Get the full timeline:
Most recent: Clinical Trial Update: Comparative, Pharmacokinetic and Pharmacodynamic Study of Subcutaneous Injections of INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects. [Phase 1]